journal cover

Medical Therapies for Heart Failure With Preserved Ejection Fraction

Hypertension

Dec 4, 2019

Sverre E KjeldsenFaiez Zannad

Abstract

Current cardiovascular pharmacotherapy targets maladaptive overactivation of the renin-angiotensin-aldosterone system (RAAS), which occurs throughout the continuum of cardiovascular disease spanning from hypertension to heart failure with reduced ejection fraction. Over the past 16 year...read more

Mentioned in this Paper

Ventricular Dysfunction, Left
Spironolactone
Renin and Aldosterone
Mineralocorticoid Receptor Antagonists
Atrial Fibrillation
Cardiovascular Diseases
Experience
Aldosterone Antagonists
Irbesartan
Hypertensive Disease
Paper Details
References
  • References
  • Citations
  • finger pointing at paper

    References currently unavailable

    We're still populating references for this paper, please check back later.
  • References
  • Citations
  • quote and clock

    No citations available

    This paper may not have been cited yet.

Similar Papers Found In These Feeds

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

HFpEF

HF-pEF is associated with left ventricular diastolic dysfunction and concentric left ventricular hypertrophy and has significant mortality and morbidity. The heterogeneity of the disease has resulted in the failure of any drugs for the treatment of HF-pEF. Here are the latest discoveries pertaining to this disease.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Drug & Digital Interventions

This feed describes how digital interventions, which are digital and mobile technologies used to support health system needs, can complement and improve pharmacotherapy in disease management. Discover the latest research on drug and digtial intervention here,

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

HFrEF

Heart failure with reduced ejection fraction (HF-rEF) is responsible for high costs and increased rates of hospital admissions along with high mortality and morbidity risks. Only treatment for HF-rEF has been shown to be efficacious compared to HF-pEF which currently has no useful treatment options. Here is the latest research on HF-rEF.

Neurohumoral Compensatory Mechanisms

The activation of neurohumoral compensatory mechanisms is a common physiological phenomenon in heart failure in order to make up for a failing heart, which will usually have a deteriorating effect on overall health condition. Discover the latest research on Neurohumoral Compensatory Mechanisms here.

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.

Coronary Artery Disease

Coronary artery disease is extremely prevalent in western societies and is the number one cause of morbidity and mortality industrialized countries. Known risk factors include hypertension, smoking and dyslipidemia. Discover the latest research on coronary artery disease here.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

© 2020 Meta ULC. All rights reserved

Medical Therapies for Heart Failure With Preserved Ejection Fraction

Hypertension

Dec 4, 2019

Sverre E KjeldsenFaiez Zannad

PMID: 31786973

DOI: 10.1161/hypertensionaha.119.14057

Abstract

Current cardiovascular pharmacotherapy targets maladaptive overactivation of the renin-angiotensin-aldosterone system (RAAS), which occurs throughout the continuum of cardiovascular disease spanning from hypertension to heart failure with reduced ejection fraction. Over the past 16 year...read more

Mentioned in this Paper

Ventricular Dysfunction, Left
Spironolactone
Renin and Aldosterone
Mineralocorticoid Receptor Antagonists
Atrial Fibrillation
Cardiovascular Diseases
Experience
Aldosterone Antagonists
Irbesartan
Hypertensive Disease

Similar Papers Found In These Feeds

Related Papers

Paper Details
References
  • References
  • Citations
  • finger pointing at paper

    References currently unavailable

    We're still populating references for this paper, please check back later.
  • References
  • Citations
  • quote and clock

    No citations available

    This paper may not have been cited yet.
/papers/medical-therapies-for-heart-failure-with/31786973